CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant Posted by Invest In Weed | Mar 12, 2019 CURE now has the right to manufacture pharmaceuticals based on both — those based on the... Read More
Corbus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Clinical Updates Posted by Invest In Weed | Mar 12, 2019 Corbus Pharmaceuticals also provided an update on its corporate progress, clinical status and... Read More